252 related articles for article (PubMed ID: 23658122)
1. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.
Shah M; Targoff IN; Rice MM; Miller FW; Rider LG;
Arthritis Rheum; 2013 Jul; 65(7):1934-41. PubMed ID: 23658122
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.
Love LA; Weinberg CR; McConnaughey DR; Oddis CV; Medsger TA; Reveille JD; Arnett FC; Targoff IN; Miller FW
Arthritis Rheum; 2009 Aug; 60(8):2499-504. PubMed ID: 19644877
[TBL] [Abstract][Full Text] [Related]
3. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
4. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
5. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
Aggarwal R; Bandos A; Reed AM; Ascherman DP; Barohn RJ; Feldman BM; Miller FW; Rider LG; Harris-Love MO; Levesque MC; ; Oddis CV
Arthritis Rheumatol; 2014 Mar; 66(3):740-9. PubMed ID: 24574235
[TBL] [Abstract][Full Text] [Related]
6. Association of Ultraviolet Radiation Exposure With Dermatomyositis in a National Myositis Patient Registry.
Parks CG; Wilkerson J; Rose KM; Faiq A; Noroozi Farhadi P; Long CS; Bayat N; Brunner HI; Goldberg B; McGrath JA; Miller FW; Rider LG
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1636-1644. PubMed ID: 31478597
[TBL] [Abstract][Full Text] [Related]
7. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.
Habers GE; Huber AM; Mamyrova G; Targoff IN; O'Hanlon TP; Adams S; Pandey JP; Boonacker C; van Brussel M; Miller FW; van Royen-Kerkhof A; Rider LG;
Arthritis Rheumatol; 2016 Mar; 68(3):761-8. PubMed ID: 26474155
[TBL] [Abstract][Full Text] [Related]
10. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
11. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease.
Okada S; Weatherhead E; Targoff IN; Wesley R; Miller FW;
Arthritis Rheum; 2003 Aug; 48(8):2285-93. PubMed ID: 12905483
[TBL] [Abstract][Full Text] [Related]
12. Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
Neely J; Long CS; Sturrock H; Kim S;
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1600-1605. PubMed ID: 30714338
[TBL] [Abstract][Full Text] [Related]
13. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.
Rider LG; Nistala K
J Intern Med; 2016 Jul; 280(1):24-38. PubMed ID: 27028907
[TBL] [Abstract][Full Text] [Related]
14. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
[TBL] [Abstract][Full Text] [Related]
15. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
Hirakata M
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
[TBL] [Abstract][Full Text] [Related]
19. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
[TBL] [Abstract][Full Text] [Related]
20. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
